406 related articles for article (PubMed ID: 8712650)
21. [Malignant hypercalcemia after treatment of breast cancer].
Bernard JD; Rimailho J; Pourrut JC; Hoff J; Bècue J
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):775-7. PubMed ID: 1469233
[TBL] [Abstract][Full Text] [Related]
22. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
Shukeir N; Arakelian A; Chen G; Garde S; Ruiz M; Panchal C; Rabbani SA
Cancer Res; 2004 Aug; 64(15):5370-7. PubMed ID: 15289344
[TBL] [Abstract][Full Text] [Related]
23. Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization.
Vargas SJ; Gillespie MT; Powell GJ; Southby J; Danks JA; Moseley JM; Martin TJ
J Bone Miner Res; 1992 Aug; 7(8):971-9. PubMed ID: 1442211
[TBL] [Abstract][Full Text] [Related]
24. Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.
Coleman RE; Fogelman I; Rubens RD
Eur J Surg Oncol; 1988 Oct; 14(5):423-8. PubMed ID: 2846366
[TBL] [Abstract][Full Text] [Related]
25. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
Clines GA; Guise TA
Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
[TBL] [Abstract][Full Text] [Related]
26. Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia.
Bandyopadhyay P; Baksi S; Bandyopadhyay D; Patel CU
Int J Clin Pract; 2003 Mar; 57(2):140-2. PubMed ID: 12661799
[TBL] [Abstract][Full Text] [Related]
27. Humoral hypercalcemia of malignancy: some enigmas on the clinical features.
Ikeda K; Ogata E
J Cell Biochem; 1995 Mar; 57(3):384-91. PubMed ID: 7768974
[TBL] [Abstract][Full Text] [Related]
28. Production of parathyroid hormone and parathyroid-hormone-related protein by breast cancer cells in culture.
Francini G; Maioli E; Petrioli R; Paffetti P; Gonnelli S; Aquino A
J Cancer Res Clin Oncol; 1993; 119(7):421-5. PubMed ID: 8491763
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
30. Development of skeletal metastases.
Kitazawa S; Maeda S
Clin Orthop Relat Res; 1995 Mar; (312):45-50. PubMed ID: 7634617
[TBL] [Abstract][Full Text] [Related]
31. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
Cisneros G; Lara LF; Crock R; Whittier FC
South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of parathyroid hormone-related protein in a squamous cell carcinoma arising from mature cystic teratoma causing humoral hypercalcemia of malignancy.
Takeuchi K; Murata K; Funaki K; Kitazawa S; Kitazawa R
Gynecol Oncol; 2000 Dec; 79(3):504-7. PubMed ID: 11104629
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
34. Production of parathyroid hormone-related protein in tumour xenografts in nude mice presenting with hypercalcaemia.
Miyake Y; Yamaguchi K; Honda S; Nagasaki K; Tsuchihashi T; Mori M; Kimura S; Abe K
Br J Cancer; 1991 Feb; 63(2):252-6. PubMed ID: 1997102
[TBL] [Abstract][Full Text] [Related]
35. Coexpression of parathyroid hormone-related protein and its receptor in breast carcinoma: a potential autocrine effector system.
Iezzoni JC; Bruns ME; Frierson HF; Scott MG; Pence RA; Deftos LJ; Bruns DE
Mod Pathol; 1998 Mar; 11(3):265-70. PubMed ID: 9521473
[TBL] [Abstract][Full Text] [Related]
36. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone related protein (PTHrP) and breast cancer.
de Vernejoul MC; Bouizar Z; Lasmoles F; Tubiana-Hulin M; Spyratos F; Gueris J; Jullienne A
Nouv Rev Fr Hematol (1978); 1991; 33(6):485-7. PubMed ID: 1818303
[TBL] [Abstract][Full Text] [Related]
38. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
Mantzoros CS; Suva LJ; Moses AC; Spark R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
40. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
Aklilu F; Park M; Goltzman D; Rabbani SA
Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
